title: Olmesartan for the prevention or delay of diabetic nephropathy: some considerations.
authors.forename: Ferrán
authors.initials: F
authors.lastname: Catalá-López
authors.forename: Gloria
authors.initials: G
authors.lastname: Martín-Serrano
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Maciá
authors.forename: Dolores
authors.initials: D
authors.lastname: Montero
mesh_terms: D000419:Albuminuria / Q000188:drug therapy*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects* / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000401:mortality*; D058065:Diabetic Cardiomyopathies / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects* / Q000627:therapeutic use*; D008297:Male; D013777:Tetrazoles / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D007093:Imidazoles; D013777:Tetrazoles